Navigation Links
Astellas Hires New Vice President of Compliance
Date:6/2/2009

DEERFIELD, Ill., June 2 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") recently hired Dan Dunham as the vice president of compliance. Dunham will be responsible for governance of the compliance program to ensure Astellas' observance of federal and state health care program requirements and regulations.

"We are very pleased to add Dan to our senior management team to provide strategic direction and leadership for the compliance department," said Seigo Kashii, president and CEO of Astellas. "He brings with him 30 years of legal, compliance and extensive pharmaceutical experience, which will accelerate Astellas toward our company goals."

Prior to joining Astellas, Dunham held legal positions at Pfizer Inc., Pharmacia Corporation and Warner-Lambert Company. He managed civil and criminal investigations into manufacturing, laboratory, marketing and promotion and pricing practices, and supervised a docket of domestic and international commercial and products liability lawsuits. While at Warner-Lambert, Dunham created and implemented that company's worldwide corporate compliance program and office. Dunham earned his law degree from Columbia University School of Law and his undergraduate degree at the University of South Dakota.

About Astellas

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the US, Astellas markets products in the areas of Immunology, Urology, Anti-Infectives, Cardiovascular and Dermatology. For more information about Astellas Pharma US, Inc., please visit our website at www.us.astellas.com.


'/>"/>
SOURCE Astellas Pharma US, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardiome And Astellas Announce Regulatory Update
2. FDA Approves Additional Indication for Astellas MYCAMINE(R)
3. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
4. Astellas Launches Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
5. Astellas Announces New Vice President of Marketing
6. Pioneer Surgical Technology Hires Vice President of New Business Development
7. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
8. LehmanMillet Continues Expansion with Strategic Hires
9. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business
10. Staffing Agency Hires Local Television News Team, Launches Broadband Network for Nurses
11. Medi-Promotions Hires Industry Executive to Expand its Medi-Scripts Prescription Pad Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: